Recent Articles

Wall Street Slides Lower in Pre-Holiday Trading

Stocks moved lower on Wall Street today, with consumer staples leading the way and telecom bringing up the rear. Crude saw some overnight volatility, while Pfizer made headlines with an inversion deal with Allergan. More 

Monday’s Vital Data: Apple Inc. (AAPL), Pfizer, Inc. (PFE) and National Bank of Greece (NBG)

Apple (AAPL) calls up on China data. Pfizer (PFE) speculation ahead of Allergan (AGN) deal. National Bank of Greece (NBG) pummeled by puts. More 

This Could Be 2015’s Biggest M&A Deal Yet

Is Pfizer trying something completely underhanded or is it genius? PFE's talks with Allergan could blow the roof off 2015 M&A activity More 

65 Upgrades and Downgrades for the Week

It pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these 65 new investment rankings More 

Friday’s Vital Data: Pfizer Inc. (PFE), Twitter Inc (TWTR) and Starbucks Corp. (SBUX)

Calls flood Pfizer (PFE) on Allergan (AGN) merger. Twitter (TWTR) growth concerns won't fade. Starbucks (SBUX) traders indecisive. More 

Stocks Inch Lower as December Hike Odds Rise

Healthcare stocks led the way, while utilities lagged and GDP growth slowed a bit in the third quarter. In after-hours, LNKD is flying high while SBUX is wafting lower. More 

Investors Should Cheer Pfizer’s Attempt to Buy Allergan (PFE, AGN)

In a massive deal, Pfizer (PFE) would get increased growth from Allergan (AGN). It would be a huge boost to Pfizer stock and pharma. More